Search

Your search keyword '"Non-small cell lung cancer -- Reports -- Forecasts and trends"' showing total 86 results
Start Over Descriptor "Non-small cell lung cancer -- Reports -- Forecasts and trends"
86 results on '"Non-small cell lung cancer -- Reports -- Forecasts and trends"'

51. Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities

Subjects
Dabrafenib -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Trametinib -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 13, 2020-: Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities (C)1994-2020 M2 [...]

Published
2020

52. Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 13, 2020-: Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:13052020 The 'Anaplastic Lymphoma Kinase Non Small Cell [...]

Published
2020

53. Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Dabrafenib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Avelumab, Necitumumab, Larotrectinib, Atezolizumab, Dacomitinib, Lorlatinib, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports, Tagrisso (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to [...]

Published
2020

54. Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030 - ResearchAndMarkets.com

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Dabrafenib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Avelumab, Necitumumab, Larotrectinib, Atezolizumab, Dacomitinib, Lorlatinib, Lung cancer, Profits, Market trend/market analysis, Business, Business, international, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports, Tagrisso (Medication) -- Reports
Abstract

DUBLIN -- The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding [...]

Published
2020

55. Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Dabrafenib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Avelumab, Necitumumab, Larotrectinib, Atezolizumab, Dacomitinib, Lorlatinib, Lung cancer, Profits, Market trend/market analysis, Business, Business, international, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports, Tagrisso (Medication) -- Reports
Abstract

M2 PRESSWIRE-May 11, 2020-: Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:11052020 The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast [...]

Published
2020

56. Non-Small Cell Lung Cancer Epidemiology Forecast: Diagnosed pool, Incidence, and Segmentation 2017-30

Subjects
Business research -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 1, 2020-: Non-Small Cell Lung Cancer Epidemiology Forecast: Diagnosed pool, Incidence, and Segmentation 2017-30 (C)1994-2020 M2 COMMUNICATIONS RDATE:01052020 As per the DelveInsight analysis, the total incident cases of [...]

Published
2020

57. Non-Small Cell Lung Cancer Global API Manufacturers, and Late-stage products

Subjects
Business research -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Non-small cell lung cancer -- Reports -- Forecasts and trends, Backup software, Lung cancer, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 1, 2020-: Non-Small Cell Lung Cancer Global API Manufacturers, and Late-stage products (C)1994-2020 M2 COMMUNICATIONS RDATE:01052020 Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III [...]

Published
2020

58. Non-Small Cell Lung Cancer Market Analysis, Market Share, Market Research Report, Leading Companies

Subjects
Merck KGaA -- Forecasts and trends -- Market research -- Market share, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends -- Market research -- Market share, Novartis Pharma AG -- Forecasts and trends -- Market research -- Market share, Pfizer Inc. -- Forecasts and trends -- Market research -- Market share, Eli Lilly and Co. -- Market research -- Forecasts and trends -- Market share, Brigatinib -- Market research -- Market share, Osimertinib -- Forecasts and trends -- Reports, Cobimetinib -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Market research -- Reports -- Forecasts and trends, Cancer research -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Romiplostim -- Market research -- Market share, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Market research -- Market share, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Antineoplastic agents -- Market research -- Market share, Canakinumab, Necitumumab, Cabozantinib, Cemiplimab, Lorlatinib, Lung cancer, Avelumab, Trametinib, Larotrectinib, Vemurafenib, Dabrafenib, Atezolizumab, Binimetinib, Dacomitinib, Profits, Marketing research, Company market share, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-April 29, 2020-: Non-Small Cell Lung Cancer Market Analysis, Market Share, Market Research Report, Leading Companies (C)1994-2020 M2 COMMUNICATIONS RDATE:29042020 LAS VEGAS - - The growth of NSCLC Market [...]

Published
2020

59. North American Tissue Diagnostics Market (2019 to 2025) - Featuring Alere, Biogenex Laboratories and Cell Signalling Technology Among Others - ResearchAndMarkets.com

Subjects
Stomach cancer -- Forecasts and trends -- Reports, Immunohistochemistry -- Forecasts and trends -- Reports, Prostate cancer -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Breast cancer, Technology, Cancer, Tumors, Lung cancer, Diseases, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'North American Tissue Diagnostics Market 2019-2025' report has been added to ResearchAndMarkets.com's offering. The North American tissue diagnostics market is anticipated to grow at a CAGR 6.6% [...]

Published
2020

60. Global Lung Cancer Therapeutics Market Study, 2019-2025

Subjects
Cancer research -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Displays (Marketing), Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Lung Cancer Therapeutics - Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. The Lung Cancer [...]

Published
2019

61. Global Lung Cancer Therapeutics Market Study, 2019-2025

Subjects
Cancer research -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Displays (Marketing), Lung cancer, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, Dec 30, 2019 (GLOBE NEWSWIRE via COMTEX) -- The 'Lung Cancer Therapeutics - Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. The Lung Cancer Therapeutics [...]

Published
2019

62. Global Immune Checkpoint Inhibitors Market Outlook 2022: NSCLC & Melanoma Showing Greatest Contributions to the IO Market

Subjects
Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Reports -- Forecasts and trends, Atezolizumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Avelumab -- Reports -- Forecasts and trends, Immunotherapy -- Reports -- Forecasts and trends, Pembrolizumab -- Reports -- Forecasts and trends, Melanoma -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Tumors, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Immune Checkpoint Inhibitors Market Outlook 2022' report has been added to ResearchAndMarkets.com's offering. The global immune checkpoint inhibitors [...]

Published
2019

63. United States Non-Small Cell Lung Cancer Market and Competitive Landscape Report 2019

Subjects
Cancer treatment -- Reports -- Forecasts and trends, Respiratory system agents -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Competition (Economics) -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 1, 2019-: United States Non-Small Cell Lung Cancer Market and Competitive Landscape Report 2019 (C)1994-2019 M2 COMMUNICATIONS RDATE:01072019 The 'US Non-Small Cell Lung Cancer Market and Competitive Landscape [...]

Published
2019

64. Lung Cancer Diagnostics Market Is Projected To Reach $3.64 Billion By 2024: Grand View Research, Inc

Subjects
Non-small cell lung cancer -- Reports -- Forecasts and trends, Cancer research -- Reports -- Forecasts and trends, Small cell lung cancer, Biological markers, Lung cancer, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-April 8, 2019-: Lung Cancer Diagnostics Market Is Projected To Reach $3.64 Billion By 2024: Grand View Research, Inc. (C)1994-2019 M2 COMMUNICATIONS RDATE:08042019 According to report published by Grand [...]

Published
2019

65. Programmed Death-Ligand 1 PD-L1 Non-Small Cell Lung Cancer NSCLC Market Insights and Forecasts, 2017-2030 - ResearchAndMarkets.com

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, Canakinumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Avelumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Cemiplimab -- Forecasts and trends -- Reports, Market trend/market analysis, Health
Abstract

2020 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market [...]

Published
2020

66. Research and Markets Adds Report: Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, Business, Business, international, Telecommunications industry
Abstract

Research and Markets has announced the addition of the 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' report [...]

Published
2020

67. Research and Markets Issues Report: Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer

Subjects
Cancer research -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, Business, Business, international, Telecommunications industry
Abstract

Research and Markets has announced the addition of the 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' report to its offerings. In [...]

Published
2020

68. Companion Diagnostics Market - Latest Trends, Forecast, and Opportunity Analysis

Subjects
Market research -- Reports -- Forecasts and trends, Biomedical laboratories -- Reports -- Forecasts and trends, Evidence-based medicine -- Reports -- Forecasts and trends, Nervous system diseases -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Colorectal cancer -- Reports -- Forecasts and trends, Communicable diseases, Profits, Competition (Economics), Breast cancer, Lung cancer, Technology, Marketing research, Market trend/market analysis, Business, Business, international
Abstract

Companion Diagnostics Market research report is a global study offering rich insights on market forecasts, latest market trends, market competition, and opportunity analysis.Stratview Research announces the launch of a new [...]

Published
2018

69. $100 Billion Immuno-Oncology Market: NSCLC & Melanoma Showing Greatest Contributions to the IO Market

Subjects
Melanoma -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Cancer vaccines -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Leukemia -- Reports -- Forecasts and trends, Vaccines, Cancer, Lung cancer, Tumors, Motor vehicle drivers, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)], By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022' report [...]

Published
2018

70. Global Non-Small Cell Lung Cancer Market and Competitive Landscape Report 2018 - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN:Research and Markets has issued the following press release: -The 'Global Non-Small Cell Lung Cancer Market and Competitive Landscape - 2018' report has been added to ResearchAndMarkets.com's offering. Global Non-Small [...]

Published
2018

71. Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers, by Regions, by Application

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Company market share, Market trend/market analysis, General interest
Abstract

India, Oct. 5 -- size:12.0ptLung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness [...]

Published
2018

72. Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers, by Regions, by Application

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Company market share, Market trend/market analysis, General interest
Abstract

India, Oct. 5 -- size:12.0pt'>Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness [...]

Published
2018

73. ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model

Subjects
Diagnostic reagents -- Reports -- Forecasts and trends, Medical testing products -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Small cell lung cancer, Accounting, Cancer, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: ReportLinker FR has issued the following press release: Reportlinker.com announces the release of the report 'ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model' - [...]

Published
2018

74. Lung Cancer Market 2018 Global Key Players | By Type: NSCLC and SCLC | Shares Analysis, Key Development Strategies and Forecasts Till 2025

Subjects
Market research -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Marketing research, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 3, 2018-: Lung Cancer Market 2018 Global Key Players | By Type: NSCLC and SCLC | Shares Analysis, Key Development Strategies and Forecasts Till 2025 (C)1994-2018 M2 COMMUNICATIONS [...]

Published
2018

75. ALK Inhibitors for Non-small Cell Lung Cancer| A Pipeline Analysis Report 2018| Technavio

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

LONDON -- Technavio has announced their latest pipeline analysis report on the ALK inhibitors for non-small cell lung cancer . The report includes a detailed analysis of the pipeline molecules [...]

Published
2018

76. Non-Small Cell Lung Cancer Research Report 2018 - Global API Manufacturers, Marketed and Phase III Drugs Landscape - ResearchAndMarkets.com

Subjects
Drugs -- Reports -- Forecasts and trends -- Intellectual property, Cancer research -- Reports -- Forecasts and trends, Marketing -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report has been added to ResearchAndMarkets.com's offering. Non-Small Cell Lung Cancer - [...]

Published
2018

77. Non-Small Cell Lung Cancer Research Report 2018 - Global API Manufacturers, Marketed and Phase III Drugs Landscape

Subjects
Drugs -- Reports -- Forecasts and trends -- Intellectual property, Cancer research -- Reports -- Forecasts and trends, Marketing -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 12, 2018-: Non-Small Cell Lung Cancer Research Report 2018 - Global API Manufacturers, Marketed and Phase III Drugs Landscape (C)1994-2018 M2 COMMUNICATIONS RDATE:12022018 The 'Non-Small Cell Lung Cancer [...]

Published
2018

78. Non-Small Cell Lung Cancer (NSCLC) Market - Overview, Technology Advancement, EpiCast Report, Future Forecast to 2025

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 8, 2017-: Non-Small Cell Lung Cancer (NSCLC) Market - Overview, Technology Advancement, EpiCast Report, Future Forecast to 2025 (C)1994-2017 M2 COMMUNICATIONS RDATE:07092017 The 'Non-Small Cell Lung Cancer (NSCLC) [...]

Published
2017

79. Global Lung Cancer Therapeutics Market to Reach $11 Billion by 2020 - Growing Demand for Targeted Therapies - Research and Markets

Subjects
Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- Research and Markets has announced the addition of the 'Global Lung Cancer Therapeutics Market 2016-2020' report to their offering. The report forecasts the global lung cancer therapeutics market [...]

Published
2016

80. Non-Small Cell Lung Cancer Therapeutics Market to Reach USD 10.5 Billion by 2020, Recent Findings by iHealthcareAnalyst, Inc

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Marketing research, Market trend/market analysis, Business
Abstract

Maryland Heights, MO, August 08, 2016 --(PR.com)-- The global non-small cell lung cancer therapeutics market is estimated to reach USD 10.5 Billion in 2020, growing at a CAGR of 11.8% [...]

Published
2016

81. NSCLC Therapeutics Market is Expected to Cross Over $2 Billion By 2019: Radiant Insights

Subjects
Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-March 2, 2016-: NSCLC Therapeutics Market is Expected to Cross Over $2 Billion By 2019: Radiant Insights (C)1994-2016 M2 COMMUNICATIONS RDATE:01032016 Radiant Insights, Inc has announced the addition of [...]

Published
2016

82. Non-Small Cell Lung Cancer Market to 2020: Radiant Insights

Subjects
Business information services -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Business database, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Nov 13, 2015 (M2 PRESSWIRE via COMTEX) -- Summary Radiant Insights, a leading business intelligence provider, has released its latest research report, 'Non-Small Cell Lung Cancer Market to 2020 - [...]

Published
2015

83. Non-Small Cell Lung Cancer Market to 2020: Radiant Insights

Subjects
Business information services -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Business database, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 13, 2015-Radiant Insights: Non-Small Cell Lung Cancer Market to 2020: Radiant Insights (C)1994-2015 M2 COMMUNICATIONS RDATE:13112015 Summary Radiant Insights, a leading business intelligence provider, has released its latest [...]

Published
2015

84. Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 - Promising Drug Pipeline / High Cost of Therapy / Personalized Medicine

Subjects
Precision medicine -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

DUBLIN, Nov. 12, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/p8lvsq/global_nonsmall ) has announced the addition of the http://www.researchandmarkets.com/research/p8lvsq/global_nonsmall report to their offering. The global non-small cell lung cancer therapeutics market to [...]

Published
2015

85. Global Gemzar (Non Small Cell Lung Cancer) Market Overview 2010 - Acute Market Reports

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Gemzar (Medication) -- Reports
Abstract

M2 PRESSWIRE-November 5, 2015-Acute Market Reports: Global Gemzar (Non Small Cell Lung Cancer) Market Overview 2010 - Acute Market Reports (C)1994-2015 M2 COMMUNICATIONS RDATE:05112015 Acute Market Reports pharmaceuticals report, Gemzar [...]

Published
2015

86. Expert Opinion - Tarceva (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Tarceva (Medication) -- Reports
Abstract

M2 PRESSWIRE-November 3, 2015-Acute Market Reports: Expert Opinion - Tarceva (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015 (C)1994-2015 M2 COMMUNICATIONS RDATE:03112015 Acute Market Reports pharmaceuticals report, Tarceva [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results